Skip to search formSkip to main contentSkip to account menu

Macugen

National Institutes of Health

Related topics

Related topics

4 relations
0.09 ML pegaptanib 3.33 MG/ML Prefilled Syringe [Macugen]pegaptanib Prefilled Syringe [Macugen]

Broader (2)

Pegaptanib Sodiumpegaptanib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Next-generation AMD drugs to wed blockbusters
2010
2010
Comparison of Combined Therapy of Intravitreal Injection of Avastin and Macugen versus Mono-Therapy. The MAAM Study-a Pilot Study
2009
2009
Bevacizumab: a new hope?
The introduction of vascular endothelial growth factor (VEGF) antibodies has markedly improved the visual prognosis for patients… 
2008
2008
Die Therapie der vaskularisierten serösen Pigmentepithelabhebung bei AMD – Beobachtungen nach Wechsel des intravitrealen Medikamentes bei Therapieversagen
Einleitung: Methode: Ergebnisse: Schlussfolgerungen: Introduction: Method: Results: Conclusion: 
2007
2007
Safety of Macugen (pegaptanib sodium) for neovascular age-related macular degeneration (NV-AMD). After 3 years of experience
Purpose: To evaluate the safety of Macugen in the treatment of NV-AMD after 3 years experience in the V.I.S.I.O.N. trial… 
2007
2007
The suppression of early angiogenic markers by the antiangiogenic aptamer Macugen® is dose dependent
The suppression of early angiogenic markers by the antiangiogenic aptamer Macugen R is dose dependent 
2007
2007
ETDRS Vision Results of Primary Avastin (Bevacizumab) for CNV in ARMD versus Avastin Rescue After Macugen (Pegaptanib) Therapy
2007
2007
Induction/Maintenance Therapy With Ranibizumab (Lucentis) Followed by Pegaptanib (Macugen) Intravitreal Injections in the Treatment of Age-Related Macular Degeneration
2006
2006
Short-Term Intraocular Pressure Trends Following Intravitreal Pegaptanib (Macugen) Injection
Review
2006
Review
2006
Macugen (Pegaptanib Sodium), a Novel Ocular Therapeutic That Targets Vascular Endothelial Growth Factor (VEGF)
The development of Macugen (pegaptanib sodium), a pegylated antivascular endothelial growth factor (VEGF) RNA aptamer, represents… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)